CapsoVision, Inc. has disclosed a notable update regarding its beneficial ownership in a recent filing. The report indicates that Eliyahou Harari and Britt Harari, along with several family trusts, hold a substantial portion of the company’s shares. This change is significant as it reflects ongoing consolidation among key stakeholders in the company.

The filing, made on November 4, 2026, reveals that Eliyahou Harari beneficially owns 7,014,554 shares, representing approximately 13.2% of the company’s total shares outstanding. His spouse, Britt Harari, holds an additional 6,136,106 shares, accounting for about 11.5%. The Harari Family Trust and other related trusts also contribute to this ownership structure.

Background

CapsoVision, Inc., classified under the SIC code 3845, specializes in electromedical and electrotherapeutic apparatus. The company is publicly traded on the Nasdaq under the ticker symbol CV. Recent filings include a Schedule 13G/A on November 4, 2026, and an 8-K on September 28, 2026, indicating ongoing regulatory compliance and updates.

What the Filing Says

The Schedule 13G/A filing outlines the beneficial ownership of shares by Eliyahou Harari and Britt Harari, as well as the Harari Family Trust and other trusts. The filing states, "The reported total in Rows 5 and 7 includes 878,448 shares of common stock of CapsoVision, Inc. directly held by Mr. Harari." It further details that the shares held by the trusts are managed by the Hararis, who serve as trustees.

Impact

This update may affect various stakeholders, including investors and analysts monitoring CapsoVision's stock performance. The concentration of ownership among the Harari family could influence corporate governance and strategic decisions within the company. Additionally, competitors in the electromedical and electrotherapeutic apparatus sector may view this consolidation as a signal of stability or potential shifts in market strategy.

What's Next

The filing does not specify what happens next regarding these ownership changes. However, continued monitoring of CapsoVision's filings may provide further insights into the company's strategic direction and any potential implications for its operations.